Menu
Back to User profile » Dr Huijuan Qiu
Papers published by Dr Huijuan Qiu:
Unveiling the Mechanism of the ChaiShao Shugan Formula Against Triple-Negative Breast Cancer
Fan T, Huang Y, Liu Z, Huang J, Ke B, Rong Y, Qiu H, Zhang B
Drug Design, Development and Therapy 2024, 18:1115-1131
Published Date: 10 April 2024
Association of low skeletal muscle index with increased systematic inflammatory responses and interferon γ-induced protein 10 levels in patients with colon cancer
He WZ, Yang QX, Xie JY, Kong PF, Hu WM, Yang L, Yang YZ, Xie QK, Jiang C, Yin CX, Guo GF, Qiu HJ, Zhang B, Xia LP
Cancer Management and Research 2018, 10:2499-2507
Published Date: 7 August 2018
An increased number of negative lymph nodes is associated with a higher immune response and longer survival in colon cancer patients
He WZ, Xie QK, Hu WM, Kong PF, Yang L, Yang YZ, Jiang C, Yin CX, Qiu HJ, Zhang HZ, Zhang B, Xia LP
Cancer Management and Research 2018, 10:1597-1604
Published Date: 18 June 2018
A high LDL-C to HDL-C ratio predicts poor prognosis for initially metastatic colorectal cancer patients with elevations in LDL-C
Liao F, He W, Jiang C, Yin C, Guo G, Chen X, Qiu H, Rong Y, Zhang B, Xu D, Xia L
OncoTargets and Therapy 2015, 8:3135-3142
Published Date: 27 October 2015
Positive expression of programmed death ligand-1 correlates with superior outcomes and might be a therapeutic target in primary pulmonary lymphoepithelioma-like carcinoma
Jiang L, Wang L, Li PF, Zhang XK, Chen JW, Qiu HJ, Wu XD, Zhang B
OncoTargets and Therapy 2015, 8:1451-1457
Published Date: 15 June 2015
Initial LDH level can predict the survival benefit from bevacizumab in the first-line setting in Chinese patients with metastatic colorectal cancer
Yin CX, Jiang C, Liao FX, Rong YM, Cai XY, Guo GF, Qiu HJ, Chen XX, Zhang B, He WZ, Xia LP
OncoTargets and Therapy 2014, 7:1415-1422
Published Date: 11 August 2014